Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
BMC Infectious Diseases|March 8, 2017
Screening in Maternity to Ascertain Tuberculosis Status (SMATS) studyEdward Broughton, Samson Haumba, Marianne Calnan, et al.
Malaria Journal|June 30, 2021
Effectiveness of in-service training plus the collaborative improvement strategy on the quality of routine malaria surveillance data: results of a pilot study in Kayunga District, UgandaNelli Westercamp, Sarah G Staedke, Catherine Maiteki-Sebuguzi, et al.
Chinese Medical Journal|December 18, 2024
Patient-reported quality of life in Asian patients with ER+/HER2- advanced breast cancer treated with palbociclib plus letrozole in the PALOMA-4 trialBinghe Xu, Xichun Hu, Wei Li, et al.
European Urology Oncology|March 15, 2022
Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 TrialJohannes Alfred Witjes, Matthew D Galsky, Jürgen E Gschwend, et al.
Japanese Journal of Clinical Oncology|October 27, 2022
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trialYoshihiko Tomita, Ko Kobayashi, Go Kimura, et al.
Infectious Diseases and Therapy|July 28, 2025
Estimating the Value of Aztreonam-Avibactam in Treating Metallo-beta-Lactamase-Producing Enterobacterales Infections in Spain Using the STEDI AMR Value FrameworkRicard Ferrer, Sonia Luque, Luis Martínez-Martínez, et al.
Infectious Diseases and Therapy|October 23, 2024
Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015-2019)Dionysios Neofytos, Antonio Pagliuca, Katherine Houghton, et al.
The New England Journal of Medicine|June 2, 2021
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial CarcinomaDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Future Oncology (London, England)|March 15, 2023
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summaryDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Pageof 2